BAC
50
-3
COP
56
2
DHR
35
3
SRE
63
-3
MCO
73
3
CVS
48
3
AXP
66
2
SYK
64
-4
NTAP
64
2
HIG
67
4
AA
51
3
PEP
41
6
PCG
93
2
HAS
30
2
L
62
2
TGNA
53
2
FLS
73
-2
DHI
48
3
MPC
47
3
SCHW
64
2
BAC
50
-3
COP
56
2
DHR
35
3
SRE
63
-3
MCO
73
3
CVS
48
3
AXP
66
2
SYK
64
-4
NTAP
64
2
HIG
67
4
AA
51
3
PEP
41
6
PCG
93
2
HAS
30
2
L
62
2
TGNA
53
2
FLS
73
-2
DHI
48
3
MPC
47
3
SCHW
64
2
Financhill
Back

InfuSystems Holdings 10K Form

Buy
67

INFU
InfuSystems Holdings

Last Price:
9.24
Seasonality Move:
7.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INFU News And Ratings

See the #1 stock for the next 7 days that we like better than INFU

INFU Financial Statistics

Sales & Book Value

Annual Sales: $125.79M
Cash Flow: $6.43M
Price / Cash Flow: 78.74
Annual Sales: $2.61
Price / Book: 3.44

Profitability

EPS (TTM): 0.06330
Net Income (TTM): $1.48M
Gross Margin: $63.11M
Return on Equity: 2.8%
Return on Assets: 1.42%

InfuSystems Holdings Earnings Forecast

Key InfuSystems Holdings Financial Ratios

  • The Gross Profit Margin over the past 17 years for INFU is 50.17%.
  • The Selling, General & Administrative Expenses for INFU have been equal to 46.14% of Gross Profit Margin.
  • The Interest Expense is 248.85% of Operating Income.
  • The Net Earning history of INFU is 0.69% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 9 years.

InfuSystems Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: INFU
Website: infusystem.com

Debt

Debt-to-Equity Ratio: 0.5
Current Ratio: 1.98
Quick Ratio: 1.37

Price-to-Earnings

Trailing P/E Ratio: 224.75
Forward P/E Ratio: 44.95

INFU Technical Analysis vs Fundamental Analysis

Buy
67
InfuSystems Holdings (INFU) is a Buy

Is InfuSystems Holdings a Buy or a Sell?